PR Newswire: news distribution, targeting and monitoring
2014

Three-Time Gold Medalist Misty May-Treanor Teams Up with Abreva to Knock Out Cold Sores this Cold and Flu Season

New survey reveals the majority of Americans don't have their facts straight about cold sores

Share with Twitter Share with LinkedIn

PARSIPPANY, N.J., Dec. 6, 2012 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare today announced it is teaming up with Misty May-Treanor, three-time Olympic gold medalist in beach volleyball, in a campaign to knock out the myths about cold sores. According to a new survey, the majority of Americans (63 percent) cannot correctly distinguish between cold sore myths and facts, and with cold and flu season approaching and cold sore triggers all around, it's more important than ever to know how to fight cold sores fast.

(Photo: http://photos.prnewswire.com/prnh/20121206/NY24707)

The survey, conducted by Wakefield Research on behalf of Abreva®, also revealed that nearly 7 in 10 (68 percent) Americans value faster healing time over lowest price when purchasing a medication. Abreva® is clinically proven to heal cold sores fast and is the number one over-the-counter cold sore treatment recommended by pharmacists.

"I've gotten cold sores for as long as I can remember and they always seem to pop up at the worst possible time. And for me, that was right in the middle of the 2012 London Games," says Misty May-Treanor, professional beach volleyball player and three-time Olympic gold medalist. "I have been using Abreva® for years, and I stick with it because it heals my cold sores fast. When I get a cold sore, I don't tough it out, I knock it out with Abreva®."

The survey revealed over half of respondents (52 percent) are unaware that cold sores go through multiple stages of development before beginning to heal, and one in two did not realize that if left untreated, cold sores can take up to two weeks to heal.  Abreva® heals cold sores much like a prescription would but without the hassle. It penetrates deep to the root of a cold sore and helps block the spread of the virus to healthy cells.

"Other 'look-alike' cold sore treatments claim to heal cold sores as fast as Abreva® and may even imitate the packaging, but Abreva® is the only over-the-counter medication approved by the FDA that is proven to shorten healing time and duration of a cold sore," said Pam Marquess, Pharm.D, pharmacist, pharmacy chain owner and GSK spokesperson. "We're heading into prime cold sore season, with triggers like cold winter weather, cold/flu season and even stress of the upcoming holidays upon us.  So if you're one of the 80 million Americans who suffer from cold sores, be prepared to knock out your cold sores fast with Abreva®."

Abreva® is available at retailers nationwide and comes with a risk free guarantee. If you aren't completely satisfied with Abreva® for any reason, save your receipt and remaining product, and call 1-877-709-3539 to get your money back. For more information about Abreva®, please visit www.Abreva.com.

About Cold Sores
A cold sore is a blister that forms on or around the lips and is usually caused by the Herpes Simplex Virus (HSV-1). HSV-1 usually affects the lips or mouth but can spread to the eyes or genitals. Most cold sore sufferers aren't exactly sure when they first encountered the virus because HSV-1 is usually contracted early in childhood.  While it's likely that 90 percent of adults have been infected by the cold sore virus, not everyone gets cold sore outbreaks. Actually, only 20 percent to 40 percent of people will experience cold sores.

About Abreva®
Abreva is the only FDA-approved over-the-counter product to speed the healing of cold sores. Abreva contains 10 percent docosanol.   

About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its well-known brands include Nicorette® and NicoDerm® CQ, the leading smoking cessation products;  alli, the only FDA-OTC weight loss aid; as well as medicine cabinet staples, Aquafresh®, Sensodyne®, Tums®, and Breathe Right®, all of which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline®
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: GSK.com.

Misty May-Treanor and Pam Marquess are paid spokespeople for Abreva® but their opinions are their own.  

Media Relations:                       



GSK Consumer Healthcare

Deborah Bolding

deborah.g.bolding@gsk.com

(973) 889-2344

Edelman

 

Catherine McCormack

catherine.mccormack@edelman.com 

(212) 819-4816







SOURCE GlaxoSmithKline



RELATED LINKS
http://www.Abreva.com

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 
Area to test

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release